SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 485 filers reported holding SEAGEN INC in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125,086,823 | +38.0% | 589,615 | +25.2% | 0.02% | +31.6% |
| Q2 2023 | $90,650,317 | +50.3% | 471,009 | +58.2% | 0.02% | +46.2% |
| Q1 2023 | $60,300,223 | -49.7% | 297,823 | -68.1% | 0.01% | -51.9% |
| Q4 2022 | $119,798,384 | -2.3% | 932,211 | +4.0% | 0.03% | -3.6% |
| Q3 2022 | $122,665,000 | -28.4% | 896,483 | -7.4% | 0.03% | -28.2% |
| Q2 2022 | $171,268,000 | +4.5% | 967,945 | -15.0% | 0.04% | +11.4% |
| Q1 2022 | $163,958,000 | +7.3% | 1,138,205 | +15.2% | 0.04% | +16.7% |
| Q4 2021 | $152,782,000 | -26.8% | 988,237 | -19.6% | 0.03% | -31.8% |
| Q3 2021 | $208,831,000 | +12.7% | 1,229,867 | +4.8% | 0.04% | +4.8% |
| Q2 2021 | $185,295,000 | +59.7% | 1,173,641 | +40.5% | 0.04% | +44.8% |
| Q1 2021 | $116,025,000 | -37.6% | 835,555 | -21.3% | 0.03% | -39.6% |
| Q4 2020 | $186,047,000 | – | 1,062,276 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |